130 related articles for article (PubMed ID: 25731298)
1. [Is PCI effective in predicting prognosis in the era of oxaliplatin-based chemotherapy in stage IV colorectal cancer with peritoneal dissemination ?].
Hatano S; Matsuzawa T; Chika N; Tajima Y; Watanabe Y; Fukuchi M; Baba H; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1692-4. PubMed ID: 25731298
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
Leung V; Huo YR; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Jan; 43(1):144-149. PubMed ID: 27780675
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and tumor 5-FU sensitivity in patients with stage IV colorectal cancer and peritoneal dissemination.
Hasegawa S; Mukai M; Sato S; Ninomiya H; Wakui K; Komatsu N; Tajima T; Nakasaki H; Makuuchi H
Oncol Rep; 2006 May; 15(5):1185-90. PubMed ID: 16596184
[TBL] [Abstract][Full Text] [Related]
4. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
[TBL] [Abstract][Full Text] [Related]
5. Quantitative prognostic indicators of peritoneal dissemination of gastric cancer.
Yonemura Y; Bandou E; Kawamura T; Endou Y; Sasaki T
Eur J Surg Oncol; 2006 Aug; 32(6):602-6. PubMed ID: 16617004
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of oxaliplatin-based chemotherapy in Stage IV colorectal cancer patients with peritoneal carcinomatosis].
Hatano S; Matsuzawa T; Kumamoto K; Fukuchi M; Baba H; Kumagai Y; Ishibashi K; Haga N; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1981-3. PubMed ID: 24393986
[TBL] [Abstract][Full Text] [Related]
7. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
[TBL] [Abstract][Full Text] [Related]
8. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
[TBL] [Abstract][Full Text] [Related]
9. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience.
Nikolic S; Dzodic R; Zegarac M; Djurisic I; Gavrilovic D; Vojinovic V; Kocic M; Santrac N; Radlovic P; Radosavljevic D; Pupic G; Martinovic A
J BUON; 2014; 19(1):66-74. PubMed ID: 24659645
[TBL] [Abstract][Full Text] [Related]
10. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin.
Elias D; Mariani A; Cloutier AS; Blot F; Goéré D; Dumont F; Honoré C; Billard V; Dartigues P; Ducreux M
Eur J Surg Oncol; 2014 Nov; 40(11):1467-73. PubMed ID: 25086990
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the objectivity of the Japanese classification of peritoneal metastases from colorectal cancer.
Kobayashi H; Kotake K; Sugihara K;
Jpn J Clin Oncol; 2014 Oct; 44(10):898-902. PubMed ID: 25135985
[TBL] [Abstract][Full Text] [Related]
12. CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Parikh R; Valle SJ; Arrowaili A; Alzahrani N; Liauw W; Morris DL
J Surg Oncol; 2018 Mar; 117(4):725-736. PubMed ID: 29266235
[TBL] [Abstract][Full Text] [Related]
13. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change.
Bhandare M; Patil P; Pai V; Bhamre R; Engineer R; Ostwal V; Saklani A
Clin Colorectal Cancer; 2017 Jun; 16(2):e1-e6. PubMed ID: 27670895
[TBL] [Abstract][Full Text] [Related]
15. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
16. [The Significance and Limitations of Curative Resection for Peritoneal Metastases of Colorectal Cancer].
Yokomizo H; Yoshimatsu K; Yano Y; Okayama S; Sakuma A; Satake M; Yamada Y; Matsumoto A; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Kato H; Naritaka Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1446-1448. PubMed ID: 28133018
[TBL] [Abstract][Full Text] [Related]
17. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
[TBL] [Abstract][Full Text] [Related]
18. [Intraperitoneal chemotherapy with oxaliplatin after complete cytoreduction for peritoneal carcinomatosis from colorectal carcinoma: preliminary experience].
Mura G; Framarini M; Milandri C; Rosetti P; Vagliasindi A; Solfrini G; Mazza P; Verdecchia GM
Suppl Tumori; 2005; 4(3):S111-2. PubMed ID: 16437938
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of peritoneal dissemination in patients with unresectable advanced or recurrent colorectal cancer who underwent curative resection after combination chemotherapy].
Mizota S; Ikeda S; Yamauchi M; Imaoka Y; Mashima H; Okimoto S; Takakura Y; Noma M; Ohara M; Oishi K; Kohashi T; Fudaba Y; Ishimoto T; Matsugu Y; Nakahara H; Urushihara T; Shinozaki K; Itamoto T
Gan To Kagaku Ryoho; 2014 May; 41(5):595-600. PubMed ID: 24917004
[TBL] [Abstract][Full Text] [Related]
20. New Staging System for Colorectal Cancer Patients with Synchronous Peritoneal Metastasis in Accordance with the Japanese Classification of Colorectal Carcinoma: A Multi-Institutional Study.
Noura S; Ohue M; Ito Y; Miyoshi N; Kobayashi H; Kotake K; Sugihara K
Dig Surg; 2016; 33(1):66-73. PubMed ID: 26618448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]